The maker of "orphan" drugs for rare diseases may be a takeover target, Reuters said, citing sources close to several drugmakers. Big Pharma is interested in orphan drugs as patents on their blockbusters expire. No deal is imminent, and ViroPharma (VPHM) hasn't said it's for sale, the report said, but it's attracting interest because of its strong pipeline. ViroPharma declined to comment. Its shares rose 6.3% to 28.87 after hitting 30.89 intraday.
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
These proven wealth builders could be exactly what you're searching for right now.
Since 2021, Dogecoin (DOGE) has consistently been one of the largest cryptocurrencies in the market. The token has attracted tens of billions in investment and is up more than 27,000% since its launch. While the price has fallen considerably since highs, the token has held its own and performed well in 2024. Some do not see the growth stopping anytime soon. According to some analysts, DOGE could reach — and even surpass — the $100 mark. Don't Miss: Dogecoin millionaires are increasing — investor
“We’re definitely not doing what you would think somebody with our income could do with the money,” one six-figure earner said.
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.